BELVIXE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BELVIXE
Largest movements
- Cash -€7,166
down €7,166 (-46.8%), from €15,309 to €8,143
mainly Net result for the year (-€34,999) and Trade debts (-€6,631)
- Receivables within one year -€819
down €819 (-28.2%), from €2,910 to €2,090
of which Other amounts receivable: -€2,069
- Deferred charges and accrued income -€478
no longer reported in 2025 (was €478)
- Profit (loss) carried forward -€34,999
down €34,999 (-237.3%), from -€14,746 to -€49,745
- Other debts +€24,962
up €24,962 (+1633.6%), from €1,528 to €26,490
- Tax, wage and social debts +€8,205
new in 2025: €8,205
- Trade debts -€6,631
down €6,631 (-95.9%), from €6,915 to €283
- Staff costs +€58,770
up €58,770 (+1948.3%), from €3,016 to €61,787
- Gross operating margin +€38,173
up €38,173, from -€11,461 to €26,712
- Other operating charges -€300
no longer reported in 2025 (was €300)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €18,696 | €10,233 | -€8,463 | -45.3% |
| Current assets | 29/58 | €18,696 | €10,233 | -€8,463 | -45.3% |
| Amounts receivable within one year | 40/41 | €2,910 | €2,090 | -€819 | -28.2% |
| Trade receivables | 40 | - | €1,250 | +€1,250 | |
| Other amounts receivable | 41 | €2,910 | €840 | -€2,069 | -71.1% |
| Cash at bank and in hand | 54/58 | €15,309 | €8,143 | -€7,166 | -46.8% |
| Deferred charges and accrued income | 490/1 | €478 | - | -€478 | |
| Total equity and liabilities | 10/49 | €18,696 | €10,233 | -€8,463 | -45.3% |
| Equity | 10/15 | €10,254 | -€24,745 | -€34,999 | |
| Contributions | 10/11 | €25,000 | €25,000 | = | 0.0% |
| Contributions outside capital | 11 | €25,000 | €25,000 | = | 0.0% |
| Other | 1109/19 | €25,000 | €25,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€14,746 | -€49,745 | -€34,999 | -237.3% |
| Amounts payable | 17/49 | €8,443 | €34,978 | +€26,535 | +314.3% |
| Amounts payable within one year | 42/48 | €8,443 | €34,978 | +€26,535 | +314.3% |
| Trade debts | 44 | €6,915 | €283 | -€6,631 | -95.9% |
| Suppliers | 440/4 | €6,915 | €283 | -€6,631 | -95.9% |
| Taxes, remuneration and social security | 45 | - | €8,205 | +€8,205 | |
| Remuneration and social security | 454/9 | - | €8,205 | +€8,205 | |
| Other amounts payable | 47/48 | €1,528 | €26,490 | +€24,962 | +1633.6% |
| Remuneration, social security and pensions | 62 | €3,016 | €61,787 | +€58,770 | +1948.3% |
| Other operating charges | 640/8 | €300 | - | -€300 | |
| Gross operating margin | 9900 | -€11,461 | €26,712 | +€38,173 | |
| Operating profit (loss) | 9901 | -€14,778 | -€35,074 | -€20,297 | -137.3% |
| Financial income | 75/76B | €101 | €76 | -€26 | -25.3% |
| Recurring financial income | 75 | €101 | €76 | -€26 | -25.3% |
| Financial charges | 65/66B | €70 | - | -€70 | |
| Recurring financial charges | 65 | €70 | - | -€70 | |
| Profit (loss) for the period before taxes | 9903 | -€14,746 | -€34,999 | -€20,252 | -137.3% |
| Profit (loss) for the period | 9904 | -€14,746 | -€34,999 | -€20,252 | -137.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€14,746 | -€34,999 | -€20,252 | -137.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.